| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |